featured
Non-Selective Beta-Blocker Use in Cirrhosis Is Associated With a Reduced Likelihood of Hospitalisation for Infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Alimentary Pharmacology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Non-Selective Beta-Blocker Use in Cirrhotic Patients Is Associated With a Reduced Likelihood of Hospitalisation for Infection
Aliment. Pharmacol. Ther. 2021 Feb 01;53(3)418-425, R Sasso, DC RockeyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.